Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)
South Korea · Delayed Price · Currency is KRW 618.00
-18.00 (-2.83%)
At close: Jan 30, 2026
Kyung Nam Pharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 9,609 | 10,076 | -20,997 | -7,828 | -3,413 | -5,488 |
Depreciation & Amortization | 2,057 | 2,475 | 2,859 | 1,961 | 1,830 | 1,526 |
Loss (Gain) From Sale of Assets | 652.13 | 854.59 | 576.7 | 204.32 | 39.9 | 17.83 |
Asset Writedown & Restructuring Costs | 70 | 70 | 11,815 | 2,509 | -775.97 | 105.56 |
Loss (Gain) From Sale of Investments | 2,380 | 1,421 | -365.81 | -1,669 | 2,789 | -1,014 |
Loss (Gain) on Equity Investments | -54 | -108.63 | 281.96 | - | - | - |
Provision & Write-off of Bad Debts | -799 | -769.8 | 112.35 | -274.87 | 2.45 | 111.66 |
Other Operating Activities | -9,921 | -11,175 | 1,595 | 3,990 | -4,505 | 9,181 |
Change in Accounts Receivable | -1,528 | -474.18 | 908.23 | 2,655 | 3,026 | -4,970 |
Change in Inventory | -1,500 | -27.76 | 1,312 | 1,255 | -4,349 | -75.41 |
Change in Accounts Payable | 1,199 | -343.97 | 2,790 | -857.55 | -1,308 | 1,511 |
Change in Other Net Operating Assets | -1,565 | -159.34 | -193.06 | -1,874 | -2,678 | 1,709 |
Operating Cash Flow | 600.88 | 1,838 | 693.3 | 71.58 | -9,342 | 2,615 |
Operating Cash Flow Growth | - | 165.15% | 868.59% | - | - | - |
Capital Expenditures | -7,166 | -6,490 | -16,823 | -2,851 | -2,306 | -45,582 |
Sale of Property, Plant & Equipment | 1,575 | 3,470 | 71.43 | 79.5 | 11.68 | 2.35 |
Cash Acquisitions | -262.24 | -262.24 | -16,613 | - | - | -567.49 |
Divestitures | 7,867 | 8,196 | - | - | 147.13 | - |
Sale (Purchase) of Intangibles | -107.05 | -121.46 | -55.38 | -67.12 | -300.54 | -504.63 |
Investment in Securities | -738.23 | -1,770 | -11,166 | -500 | 1,662 | -3,752 |
Other Investing Activities | 2,418 | 2,574 | -137.85 | 67.06 | -482 | 279.09 |
Investing Cash Flow | -1,473 | 536.48 | -44,010 | -3,222 | -1,269 | -50,067 |
Short-Term Debt Issued | - | 7,048 | 500 | 491.72 | 5,000 | - |
Long-Term Debt Issued | - | 10,065 | 27,244 | - | 8,000 | 44,500 |
Total Debt Issued | 15,215 | 17,113 | 27,744 | 491.72 | 13,000 | 44,500 |
Short-Term Debt Repaid | - | -4,613 | -2,268 | - | - | - |
Long-Term Debt Repaid | - | -15,236 | -1,155 | -3,806 | -2,196 | -1,395 |
Total Debt Repaid | -20,013 | -19,850 | -3,423 | -3,806 | -2,196 | -1,395 |
Net Debt Issued (Repaid) | -4,799 | -2,737 | 24,320 | -3,314 | 10,804 | 43,105 |
Issuance of Common Stock | 19,460 | 19,460 | - | 27,432 | - | 2,000 |
Other Financing Activities | 5,287 | 5,459 | 1,825 | -857.14 | -48.57 | 1,203 |
Financing Cash Flow | 19,948 | 22,182 | 26,146 | 23,261 | 10,756 | 46,307 |
Foreign Exchange Rate Adjustments | 138.49 | 297.36 | 139 | -48.88 | 57.78 | -64.89 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - |
Net Cash Flow | 19,215 | 24,854 | -17,032 | 20,061 | 202.94 | -1,209 |
Free Cash Flow | -6,565 | -4,652 | -16,130 | -2,780 | -11,648 | -42,966 |
Free Cash Flow Margin | -11.68% | -7.65% | -27.20% | -4.71% | -18.02% | -60.57% |
Free Cash Flow Per Share | -121.25 | -107.03 | -454.99 | -95.26 | -509.83 | -2491.14 |
Cash Interest Paid | 1,885 | 2,289 | 1,713 | 1,186 | 1,021 | 598.96 |
Cash Income Tax Paid | 129.91 | 100.35 | 199.45 | 76.56 | -1.3 | -15.44 |
Levered Free Cash Flow | -12,588 | -10,174 | -8,591 | -2,800 | -21,802 | -30,813 |
Unlevered Free Cash Flow | -11,783 | -8,934 | -7,557 | -1,580 | -20,814 | -30,061 |
Change in Working Capital | -3,393 | -1,005 | 4,817 | 1,179 | -5,309 | -1,825 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.